February 10, 2025
Other News
SMH #1 in World for “Watchman” Treatment
Innovative device prevents strokes – without medication – in at-risk heart patients SARASOTA, Fla., Feb. 6, 2025 /PRNewswire/ — Sarasota Memorial Hospital has earned the #1 spot among the world’s WATCHMAN providers protecting people with atrial fibrillation. This week, the Sarasota…
Catheter Precision to Attend and Participate in the 13th Internation Symposium on Left Atrial Appendage
FORT MILL, S.C., Feb. 06, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced their attendance at the 13th International Symposium on Left Atrial Appendage (ISLAA). ISLAA will take place on February 7th and 8th, 2025 in Austin, Texas.
Stroke Detection Innovator Wellumio Enrolls First Patient in Australian Clinical Trial for ‘Axana’ 0.1T portable magnetic resonance imaging device (Portable MRI study)
“Revolutionary portable device leverages advanced magnetic resonance technology to rapidly detect acute stroke biomarkers, enabling frontline care teams to make faster, life-saving decisions within the critical ‘golden hour.” A Melbourne hospital images the first patient in Australia…
Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference
SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX) reported 12 month data from the Phase 2 study (SYCAMORE) of REC-994, the first industry sponsored Phase 2 trial completed in Cerebral Cavernous Malformations (CCM). The Company announced in September 2024 that the signal-finding study met its primary endpoint.
RapidAI Reveals Superiority Over Competition in LVO Detection – 33% More Cases Identified Than Leading Competitor, Alongside Numerous Abstracts at ISC 2025
SAN MATEO, Calif.–(BUSINESS WIRE)–The numbers speak for themselves, RapidAI’s deep clinical AI is delivering results where competitors are falling short. New data from the largest head-to-head study to date proves RapidAI’s LVO detection outperforms Viz.ai by a staggering 33%, detecting far more stroke cases and reducing the risk of missed […]
Centers Health Care Honored with American Heart Association Achievement Award for Cardiovascular Care Excellence
Centers Celebrates Target: BP™ During Heart Month; Hosts Jumping Jacks Challenge Across Facilities BRONX, N.Y., Feb. 5, 2025 /PRNewswire/ — Centers Health Care, the largest and most complete post-acute health care continuum in the Northeast that touches one million lives each year with…
Revalesio Announces New Analyses from Phase 2 RESCUE Study of RNS60 in Patients with Acute Ischemic Stroke in Oral Presentation at the International Stroke Conference 2025
Lowering of infarct growth – brain tissue loss – by 50% in patients treated in less than 12 hours following last known well Lowering of infarct growth correlated with clinically meaningful improvements in several functional stroke measures that evaluate a patient’s recovery TACOMA, Wash.,…
Vivistim Paired VNS Therapy Outcomes & Success at Comprehensive Stroke Centers Highlighted at ISC 2025
Dr. Ronald Benitez to present Vivistim safety and outcomes data for the largest cohort of ischemic stroke survivors AUSTIN, Texas and LOS ANGELES, Feb. 5, 2025 /PRNewswire/ — Dr. Ronald P. Benitez, a neurosurgeon at Atlantic Brain and Spine, will present safety and outcomes data from the…
Acarix Partners with Geo-Med to Extend the Availability of the CADScor System for Veterans
OKLAHOMA CITY, Feb. 5, 2025 /PRNewswire/ — Acarix, a pioneer in the development of groundbreaking acoustic-based cardiac diagnostic solutions, is proud to announce a new strategic partnership with Geo-Med, LLC, a renowned Service-Disabled Veteran-Owned Small Business that specializes in…
